CD4 and breast angiosarcoma: With the aid of our recently-developed multiplex immunohistochemistry (mIHC) technique, we could further explore the link between the infiltration of these CD4+T cell subsets (Th1, Th2, Th17, and Tregs) in the liver tissues and disease outcomes in BA patients.